Most Important Things and Associated Factors With Prioritizing Daily Life in Patients With Advanced Lung Cancer

Author:

Kameyama Naofumi12ORCID,Sato Takashi13ORCID,Arai Daisuke14ORCID,Fujisawa Daisuke56,Takeuchi Mari57,Nakachi Ichiro14,Kawada Ichiro1ORCID,Yasuda Hiroyuki1,Ikemura Shinnosuke1,Terai Hideki1ORCID,Nukaga Shigenari18,Nakano Yasushi2,Hirano Toshiyuki19,Minematsu Naoto10ORCID,Asakura Takanori111ORCID,Kamatani Takashi11213ORCID,Tanaka Kyuto1415,Suzuki Shoji111,Miyawaki Masayoshi116ORCID,Naoki Katsuhiko3ORCID,Fukunaga Koichi1ORCID,Soejima Kenzo117

Affiliation:

1. Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan

2. Division of Pulmonary Medicine, Kawasaki Municipal Ida Hospital, Kawasaki, Japan

3. Department of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara, Japan

4. Pulmonary Division, Internal Medicine, Saiseikai Utsunomiya Hospital, Utsunomiya, Japan

5. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan

6. Division of Patient Safety, Keio University School of Medicine, Tokyo, Japan

7. Palliative Care Center, Keio University Hospital, Tokyo, Japan

8. Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan

9. Department of Internal Medicine, Sano-Kosei General Hospital, Sano, Japan

10. Department of Internal Medicine, Hino Municipal Hospital, Tokyo, Japan

11. Department of Pulmonary Medicine, Saitama City Hospital, Saitama, Japan

12. Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan

13. Department of Medical Science Mathematics, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan

14. Division of Pulmonary Medicine, Kawasaki Municipal Kawasaki Hospital, Kawasaki, Japan

15. Department of Respiratory Medicine, Nippon Kokan Hospital, Kawasaki, Japan

16. Department of Pulmonary Medicine, Eiju General Hospital, Tokyo, Japan

17. Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan

Abstract

PURPOSE: Patients' values and priorities in their lives should be appreciated from an early phase of incurable diseases such as advanced cancer. However, studies examining these characteristics have been lacking. This study attempted to determine what patients with advanced lung cancer valued most, once they had been diagnosed, and any associated factors. METHODS: Patients with newly diagnosed advanced lung cancer (N = 248) were enrolled in a questionnaire survey conducted at 16 hospitals in Japan. Their priorities were assessed using a free-text response to the question what is the most important thing to you now? at the time of diagnosis and 3 months after diagnosis. The free-text responses were classified into 10 categories for quantification. The clinical characteristics associated with the category describing daily life were further examined. RESULTS: Free-text comments were obtained from 103 (44.0%) and 66 (42.6%) patients at the time of diagnosis and at 3 months, respectively. The most frequent categories were family (at diagnosis: 50.5%; at 3 months: 50.0%) and daily life (at diagnosis: 33.0%; at 3 months: 36.4%), followed by health (at diagnosis: 32.0%; at 3 months: 27.3%) at both time points. The patients mentioning daily life, the issues related to how to spend daily life, showed significantly higher total scores and functional well-being subscale scores on the Functional Assessment of Cancer Therapy-Lung scale at both time points and lower depression scores at diagnosis and lower anxiety scores at 3 months on the Hospital Anxiety and Depression Scale. CONCLUSION: Family and daily life were highly valued by patients with advanced lung cancer at diagnosis. A better quality of life and better mood were associated with mentioning daily life, which should be taken into account in care planning to maintain patients' involvement in daily life even with incurable diseases.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Oncology (nursing),Health Policy,Oncology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3